医学临床研究
  2025年4月5日 星期六           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2023, Vol. 40 Issue (11): 1680-1682    DOI: 10.3969/j.issn.1671-7171.2023.11.019
  论著 本期目录 | 过刊浏览 | 高级检索 |
减重代谢外科病人综合管理平台在肥胖2型糖尿病减重代谢手术患者中的应用效果
郭小霞1, 贾丽娜2, 罗雁归1*
1.西安市人民医院(西安市第四医院)血液净化科,陕西 西安 710004;
2.西安交通大学第一附属医院捐献器官获取与分配科,陕西 西安 710061
Effect of Integrated Management Platform for Patients with Weight Loss Metabolic Surgery in Obesity Type 2 Diabetes
GUO Xiaoxia, JIA Lina, LUO Yangui
Department of Blood Purification,Xi'an People's Hospital(Xi'an Fourth Hospital),Shaanxi Xi'an 710004
全文: PDF (2265 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨减重代谢外科病人综合管理平台在肥胖2型糖尿病减重代谢手术患者中的应用效果。【方法】采用抽样调查法选取2018年3月至2019年3月在西安市人民医院(西安市第四医院)就诊的65例肥胖2型糖尿病减重代谢手术患者作为对照组,进行常规信息化管理,选取2019年4月至2020年5月在西安市人民医院(西安市第四医院)就诊的65例肥胖2型糖尿病减重代谢手术患者作为观察组,比较两组患者术后体重指数(BMI)、术后并发症持续时间、血糖指标。【结果】与对照组比较,观察组患者术后6个月、术后12个月的BMI显著降低(P<0.01),术后呕吐、便秘、腹泻、脱发的持续时间更短(P<0.01),术后12个月的空腹血糖(FPG)、餐后2 h血糖(2hPG)、糖化血红蛋白(HbA1c)水平更低(P<0.05)。【结论】减重代谢外科病人综合管理平台用于肥胖2型糖尿病减重代谢手术患者中,可下调患者BMI,减少术后并发症持续时间,促进术后血糖趋近正常水平。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
郭小霞
贾丽娜
罗雁归
关键词 肥胖症/外科学糖尿病,2型/外科学疾病管理    
Abstract:【Objective】To explore the effect of comprehensive management platform for bariatric and metabolic surgery patients with type 2 diabetes mellitus. 【Methods】A sampling survey method was used to select 65 obese patients with type 2 diabetes who underwent bariatric metabolic surgery at Xi'an People's Hospital(Xi'an Fourth Hospital) from March 2018 to March 2019 as the control group for routine information management. Another 65 obese patients with type 2 diabetes who underwent bariatric metabolic surgery at Xi'an People's Hospital(Xi'an Fourth Hospital) from April 2019 to May 2020 were selected as the observation group for comprehensive management platform for bariatric and metabolic surgery patients. The postoperative body mass index(BMI),duration of postoperative complications,and blood glucose indicators were compared between the two groups.【Results】The BMI level of 6 months and 12 months after operation in the observation group was significantly lower than that in the control group(P<0.01). Compared to the control group,the duration of vomiting,constipation,diarrhea and alopecia was shorter in the observation group(P<0.01). And the levels of FPG,2hPG and HbA1c in the observation group at 12 month after surgery were lower than those in the control group(P<0.05). 【Conclusion】The comprehensive management platform used in obese patients with type 2 diabetes and bariatric and metabolic surgery can lower the patient's BMI,reduce the duration of postoperative complications,and promote postoperative blood sugar to approach normal levels. operation.
Key wordsObesity/SU    Diabetes Mellitus, Type 2/SU    Disease Management
收稿日期: 2022-11-25     
中图分类号:  R587.1  
通讯作者: * E-mail:xahlxhxt@163.com   
引用本文:   
郭小霞, 贾丽娜, 罗雁归. 减重代谢外科病人综合管理平台在肥胖2型糖尿病减重代谢手术患者中的应用效果[J]. 医学临床研究, 2023, 40(11): 1680-1682.
GUO Xiaoxia, JIA Lina, LUO Yangui. Effect of Integrated Management Platform for Patients with Weight Loss Metabolic Surgery in Obesity Type 2 Diabetes. JOURNAL OF CLINICAL RESEARCH, 2023, 40(11): 1680-1682.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2023.11.019     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2023/V40/I11/1680
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn